Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $34.5253 per ML under NDC 00548571100. Its NADAC has been published 297 times since Sep 25, 2019.
FDA first approved this application on Nov 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548571100
Classification
Generic
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
5/21/2025
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077334FDA Approved
11/28/2017
TE Code
AB
On Market Since
11/28/2017
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 297 times since Sep 25, 2019, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.5253 per ML |
|---|---|
| All-time high | $60.0285 (Nov 13, 2019) |
| All-time low | $28.0375 (May 22, 2024) |
| Median price | $43.5023 |
| Average price | $43.6840 |
| Largest weekly change | +39.7% (Aug 21, 2024) |
| Weeks tracked | 297 |
| Tracking since | Sep 25, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.8%
5Y
-24.8%
All
-39.9%
Last surveyed May 28, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amphastar Pharmaceuticals, Inc., is $34.5253 per ML (NDC 00548571100), effective May 28, 2025.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 39.9%. It has been tracked across 297 weekly CMS publications since Sep 25, 2019.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Sep 25, 2019, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $28.0375 (May 22, 2024) to a high of $60.0285 (Nov 13, 2019), with a median of $43.5023 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.3134 per ML — about 47% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 00548571100) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.